Insider Transactions in Q1 2021 at Aurinia Pharmaceuticals Inc. (AUPH)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 12
2021
|
Neil Solomons Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
40,000
-17.6%
|
$520,000
$13.49 P/Share
|
|
Mar 12
2021
|
Neil Solomons Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+14.96%
|
$120,000
$3.02 P/Share
|
|
Mar 05
2021
|
George M Milne Jr Director |
BUY
Open market or private purchase
|
Direct |
5,000
+10.0%
|
$65,000
$13.0 P/Share
|
|
Jan 29
2021
|
Michael R Hayden Director |
BUY
Exercise of conversion of derivative security
|
Direct |
95,000
+30.3%
|
$475,000
$5.97 P/Share
|
|
Jan 29
2021
|
Jill Leversage Director |
BUY
Open market or private purchase
|
Direct |
1,200
+50.0%
|
$19,200
$16.03 P/Share
|
|
Jan 29
2021
|
Jill Leversage Director |
BUY
Open market or private purchase
|
Indirect |
400
+50.0%
|
$6,400
$16.03 P/Share
|
|
Jan 28
2021
|
Stephen P. Robertson EVP, General Counsel |
BUY
Open market or private purchase
|
Direct |
900
+24.86%
|
$14,400
$16.14 P/Share
|